 was the ﬁrst to investigate the
impact of statins on CEA outcomes. In a series of nearly

1600 patients with either symptomatic or asymptomatic
carotid stenoses undergoing CEA, statin use was associated with a 3-fold reduction in 30-day stroke (P ¼ .019)
and a 5-fold decrease in 30-day mortality (P ¼ .049).90
Other studies con